0
     

Report Added
Report already added
Colon & Rectal Carcinoma Market - Global Outlook and Forecast 2022-2028

Colon & Rectal Carcinoma Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Colon & Rectal Carcinoma in Global, including the following market information:

Global Colon & Rectal Carcinoma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colon & Rectal Carcinoma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Colon Carcinoma Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colon & Rectal Carcinoma include Pfizer, Bayer Healthcare, Spectrum, Novartis, Amgen, Roche and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colon & Rectal Carcinoma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Colon & Rectal Carcinoma Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colon & Rectal Carcinoma Market Segment Percentages, by Type, 2021 (%)
Colon Carcinoma Treatment
Rectal Carcinoma Treatment
Global Colon & Rectal Carcinoma Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colon & Rectal Carcinoma Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Colon & Rectal Carcinoma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colon & Rectal Carcinoma Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colon & Rectal Carcinoma revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colon & Rectal Carcinoma revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Colon & Rectal Carcinoma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colon & Rectal Carcinoma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colon & Rectal Carcinoma Overall Market Size
2.1 Global Colon & Rectal Carcinoma Market Size: 2021 VS 2028
2.2 Global Colon & Rectal Carcinoma Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colon & Rectal Carcinoma Players in Global Market
3.2 Top Global Colon & Rectal Carcinoma Companies Ranked by Revenue
3.3 Global Colon & Rectal Carcinoma Revenue by Companies
3.4 Top 3 and Top 5 Colon & Rectal Carcinoma Companies in Global Market, by Revenue in 2021
3.5 Global Companies Colon & Rectal Carcinoma Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colon & Rectal Carcinoma Players in Global Market
3.6.1 List of Global Tier 1 Colon & Rectal Carcinoma Companies
3.6.2 List of Global Tier 2 and Tier 3 Colon & Rectal Carcinoma Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Colon & Rectal Carcinoma Market Size Markets, 2021 & 2028
4.1.2 Colon Carcinoma Treatment
4.1.3 Rectal Carcinoma Treatment
4.2 By Type - Global Colon & Rectal Carcinoma Revenue & Forecasts
4.2.1 By Type - Global Colon & Rectal Carcinoma Revenue, 2017-2022
4.2.2 By Type - Global Colon & Rectal Carcinoma Revenue, 2023-2028
4.2.3 By Type - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colon & Rectal Carcinoma Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Colon & Rectal Carcinoma Revenue & Forecasts
5.2.1 By Application - Global Colon & Rectal Carcinoma Revenue, 2017-2022
5.2.2 By Application - Global Colon & Rectal Carcinoma Revenue, 2023-2028
5.2.3 By Application - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Colon & Rectal Carcinoma Market Size, 2021 & 2028
6.2 By Region - Global Colon & Rectal Carcinoma Revenue & Forecasts
6.2.1 By Region - Global Colon & Rectal Carcinoma Revenue, 2017-2022
6.2.2 By Region - Global Colon & Rectal Carcinoma Revenue, 2023-2028
6.2.3 By Region - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Colon & Rectal Carcinoma Revenue, 2017-2028
6.3.2 US Colon & Rectal Carcinoma Market Size, 2017-2028
6.3.3 Canada Colon & Rectal Carcinoma Market Size, 2017-2028
6.3.4 Mexico Colon & Rectal Carcinoma Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Colon & Rectal Carcinoma Revenue, 2017-2028
6.4.2 Germany Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.3 France Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.4 U.K. Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.5 Italy Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.6 Russia Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.7 Nordic Countries Colon & Rectal Carcinoma Market Size, 2017-2028
6.4.8 Benelux Colon & Rectal Carcinoma Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Colon & Rectal Carcinoma Revenue, 2017-2028
6.5.2 China Colon & Rectal Carcinoma Market Size, 2017-2028
6.5.3 Japan Colon & Rectal Carcinoma Market Size, 2017-2028
6.5.4 South Korea Colon & Rectal Carcinoma Market Size, 2017-2028
6.5.5 Southeast Asia Colon & Rectal Carcinoma Market Size, 2017-2028
6.5.6 India Colon & Rectal Carcinoma Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Colon & Rectal Carcinoma Revenue, 2017-2028
6.6.2 Brazil Colon & Rectal Carcinoma Market Size, 2017-2028
6.6.3 Argentina Colon & Rectal Carcinoma Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colon & Rectal Carcinoma Revenue, 2017-2028
6.7.2 Turkey Colon & Rectal Carcinoma Market Size, 2017-2028
6.7.3 Israel Colon & Rectal Carcinoma Market Size, 2017-2028
6.7.4 Saudi Arabia Colon & Rectal Carcinoma Market Size, 2017-2028
6.7.5 UAE Colon & Rectal Carcinoma Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Colon & Rectal Carcinoma Major Product Offerings
7.1.4 Pfizer Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporate Summary
7.2.2 Bayer Healthcare Business Overview
7.2.3 Bayer Healthcare Colon & Rectal Carcinoma Major Product Offerings
7.2.4 Bayer Healthcare Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.2.5 Bayer Healthcare Key News
7.3 Spectrum
7.3.1 Spectrum Corporate Summary
7.3.2 Spectrum Business Overview
7.3.3 Spectrum Colon & Rectal Carcinoma Major Product Offerings
7.3.4 Spectrum Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.3.5 Spectrum Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Colon & Rectal Carcinoma Major Product Offerings
7.4.4 Novartis Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 Amgen
7.5.1 Amgen Corporate Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Colon & Rectal Carcinoma Major Product Offerings
7.5.4 Amgen Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.5.5 Amgen Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Colon & Rectal Carcinoma Major Product Offerings
7.6.4 Roche Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.6.5 Roche Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Colon & Rectal Carcinoma Major Product Offerings
7.7.4 Merck Colon & Rectal Carcinoma Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Colon & Rectal Carcinoma Market Opportunities & Trends in Global Market
Table 2. Colon & Rectal Carcinoma Market Drivers in Global Market
Table 3. Colon & Rectal Carcinoma Market Restraints in Global Market
Table 4. Key Players of Colon & Rectal Carcinoma in Global Market
Table 5. Top Colon & Rectal Carcinoma Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Colon & Rectal Carcinoma Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Colon & Rectal Carcinoma Revenue Share by Companies, 2017-2022
Table 8. Global Companies Colon & Rectal Carcinoma Product Type
Table 9. List of Global Tier 1 Colon & Rectal Carcinoma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colon & Rectal Carcinoma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Colon & Rectal Carcinoma Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Colon & Rectal Carcinoma Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Colon & Rectal Carcinoma Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Colon & Rectal Carcinoma Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Colon & Rectal Carcinoma Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Colon & Rectal Carcinoma Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Colon & Rectal Carcinoma Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Colon & Rectal Carcinoma Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Colon & Rectal Carcinoma Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Colon & Rectal Carcinoma Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Colon & Rectal Carcinoma Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Colon & Rectal Carcinoma Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Colon & Rectal Carcinoma Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Colon & Rectal Carcinoma Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Colon & Rectal Carcinoma Product Offerings
Table 32. Pfizer Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Healthcare Corporate Summary
Table 34. Bayer Healthcare Colon & Rectal Carcinoma Product Offerings
Table 35. Bayer Healthcare Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 36. Spectrum Corporate Summary
Table 37. Spectrum Colon & Rectal Carcinoma Product Offerings
Table 38. Spectrum Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Colon & Rectal Carcinoma Product Offerings
Table 41. Novartis Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Corporate Summary
Table 43. Amgen Colon & Rectal Carcinoma Product Offerings
Table 44. Amgen Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Colon & Rectal Carcinoma Product Offerings
Table 47. Roche Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Colon & Rectal Carcinoma Product Offerings
Table 50. Merck Colon & Rectal Carcinoma Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Colon & Rectal Carcinoma Segment by Type in 2021
Figure 2. Colon & Rectal Carcinoma Segment by Application in 2021
Figure 3. Global Colon & Rectal Carcinoma Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Colon & Rectal Carcinoma Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Colon & Rectal Carcinoma Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colon & Rectal Carcinoma Revenue in 2021
Figure 8. By Type - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 9. By Application - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 10. By Region - Global Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 11. By Country - North America Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 12. US Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 16. Germany Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 17. France Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 24. China Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 28. India Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 30. Brazil Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Colon & Rectal Carcinoma Revenue Market Share, 2017-2028
Figure 33. Turkey Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Colon & Rectal Carcinoma Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Healthcare Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Spectrum Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Colon & Rectal Carcinoma Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Colon & Rectal Carcinoma Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027